The influence of β-hydroxy-β-methylbutyrate
(HMB) on proliferation and differentiation of myogenic cells has been
well-studied. However, the role of HMB in myofiber specification and
potential mechanisms is largely unknown. Thus, the objective of this
research was to explore the role of HMB supplementation in myofiber
specification. Results showed that HMB treatment significantly increased
the fast MyHC protein level (mice: 1.59 ± 0.08, P < 0.01; C2C12: 2.26 ± 0.11, P < 0.001),
decreased the slow MyHC protein level (mice: 0.76 ± 0.05, P < 0.05; C2C12: 0.52 ± 0.02, P < 0.001), and increased the miR-199a-3p level (mice: 4.93 ±
0.37, P < 0.001; C2C12: 11.25 ± 0.57, P < 0.001). Besides, we also observed that HMB promoted
the activity of glycolysis-related enzymes and reduced the activities
of oxidation-related enzymes in mice and C2C12 cells. Overexpression
of miR-199a-3p downregulated the slow MyHC protein level (0.71 ±
0.02, P < 0.01) and upregulated the fast MyHC
protein level (2.13 ± 0.09, P < 0.001), while
repression of miR-199a-3p exhibited the opposite effect. Target identification
results verified that miR-199a-3p targets the 3′UTR of the
TEA domain family member 1 (TEAD1) to cause its post-transcriptional
inhibition (0.41 ± 0.07, P < 0.01). Knockdown
of TEAD1 exhibited a similar effect with miR-199a-3p on myofiber specification.
Moreover, suppression of miR-199a-3p blocked slow-to-fast myofiber
type transition induced by HMB. Together, our finding revealed that
miR-199-3p is induced by HMB and contributes to the action of HMB
on slow-to-fast myofiber type conversion via targeting TEAD1.